A collaboration between scientists at Rutgers and Scripps Research led to the discovery of a small molecule that may slow down or stop the progression of Parkinson’s disease, a neurodegenerative disorder with no cure that affects 1 million people in the United States. To read the full article.
Recent Posts
- NJACTS Community Engagement Core COVID-19 Resources
- Adverse Childhood Experiences Influence Potentially Dangerous Firearm-Related Behavior in Adulthood.
- NJ joins lawsuit against Trump over cuts to medical research that would hit Rutgers.
- Simulation Training: A Powerful Tool to Bridge Theory and Practice.
- New NJACTS Publication
Categories
- Community (2,139)
- Covid (982)
- CTO Events (6)
- News (2,729)
- Pilots (21)